REFERENCES
- Agreement on Trade-Related Aspects of Intellectual Property (15 April 1994) LT/UR/A-1c/IP/1art.
- Benisheva-Dimitrova T. (2010) Biotech. Biotechnol. Eq., 24, 2049–2053.
- Clark L.T. (2003) Am. Heart J., 145, 387–396.
- Cohen J.C., Gyansa-Lutterold M., Torpey K., Esmal L.C., Kurocava G. (2005) Globalisation and health, 1, 17, 1–10 doi: 10.1186/1744–8603–1–17
- Correa C.M. (2002) Global Social Policy, 3, 261–278.
- Council Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/Ec on the Community code relating to medicinal products for human use, Official Journal of the European Union, 30/4/2004, L 136, 34–57.
- Emerton D. (2006) J. Generic Medicines, 4, 73–78.
- Ess S.M., Schneeweiss S., Szucs T.D. (2003) Pharmacoeconomics, 2, 89–103.
- Fiona M. (1997) NBER (National Bureau of economic Research) Working Paper Series, No. 6190, Cambridge, 8.
- Fox P.D. (2003–2004) Health Care Financing Review, 25, 7–21.
- DrugPatentWatch, http://www.drugpatentwatch.com (Accessed January 2006—July 2009).
- EPO Espacenet, www.espacenet.com (Accessed January 2006–July 2009).
- Howard L. (2007) J. Generic Medicines, 4, 230–236.
- Howard L. (2007) J. Generic Medicines, 4, 302–305.
- Howard L. (2007) J. Generic Medicines, 5, 85–90.
- Jannuzzi A., Vasconcellos A., de Souza C. (2008) Cad. Saúde Pública, Rio de Janeiro, 24, 1205–1218.
- Magazzini L., Pammolli F., Riccaboni M. (2004) The European J. Health Economics, 2(5), 175–182.
- Manova M., Stoimenova A., Clerfeuille F., Petrova G. (2011) J. Public Health, 19, 91–100.
- Mansley E.C., Teutsch S.M., White D.M., Busza J.D., Geisel S.S. (2008) Forum for Health Economics and Policy, 11, 11–18.
- Mossialos E., Mrazek M., Walley T. (2004) European Observatory on Health Systems and Policies, Oxford University Press, London.
- Orange Book: Aapproved drug products with therapeutics equivalence evaluation. http://www.accessdata.fda.gov/ (Accessed trough January 2006—July 2009).
- del Pozo Javier García, Eduardo Ramos Sevillano, Francisco J. de Abajo, Ramona Mateos Campos (2004) Revista Espanola de Cardiologia, 57(3), 241–249.
- Sibbald B. (2001) CMAJ, 164(9),1333.
- Tinetti M. (2008) NEJM, 25, 2728–2732.
- WHO. Executive Board (2003) 115 session. International Nonproprietary Names: revised procedure. Documents EB112/3 and EB112/2003/REC/1, summary record of the first meeting, section 4, http://apps.who.int/gb/ebwha/pdf_files/EBH5/B115_11-en.pdf (Accessed 16 June 2009).